Your session is about to expire
← Back to Search
Dietary Supplement
Flaxseed for High Blood Pressure
Phase 2 & 3
Waitlist Available
Led By Grant N Pierce, Ph.D.
Research Sponsored by St. Boniface Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
This trial tests if eating ground-up flaxseed every day can lower blood pressure in people who are newly diagnosed with high blood pressure and haven't started any medication. The nutrients in flaxseed might help relax blood vessels and reduce blood pressure. Flaxseed has been shown to reduce blood pressure in hypertensive patients through its components like ω-3 fatty acids, lignans, and fiber.
Eligible Conditions
- High Blood Pressure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Side effects data
From 2016 Phase 2 & 3 trial • 110 Patients • NCT0078195012%
Increased Claudication
5%
Nausea
5%
Stroke
3%
Rest Pain in Limbs
2%
Myocardial Infarction
2%
Ulcerative Cellulitis
2%
Death
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Flaxseed
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: FlaxseedExperimental Treatment1 Intervention
30 grams of milled flaxseed on its own or baked into food products (ie: bagels, muffins, and snack bars)
Group II: Wheat/Mixed Dietary OilsPlacebo Group1 Intervention
A combination of wheat, pecans, and/or mixed dietary oils on its own or baked into food products (ie: bagels, muffins, and snack bars)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Flaxseed
2012
Completed Phase 3
~600
Find a Location
Who is running the clinical trial?
St. Boniface HospitalLead Sponsor
54 Previous Clinical Trials
14,984 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,518,023 Total Patients Enrolled
Grant N Pierce, Ph.D.Principal InvestigatorSt. Boniface Hospital Research Centre
Share this study with friends
Copy Link
Messenger